Jared Kaltwasser

A new study highlights the role a qualified specialty pharmacist can play in driving down costs across a health plan.

A study of patients with inflammatory conditions who were prescribed biologic disease-modifying anti-rheumatic drugs had lower rates of chronic opioid use if they were adherent to their biologic therapy, according to new research.